Palmitic acid (PA), which is a kind of SFA, in cooperation with receptor toll-like type 2 (TLR2) have been shown in vitro to activate inflammation in the development of NASH. This evidence concerns the gene TLR2 and metabolic dysfunction-associated steatohepatitis.